Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prenatal pyrimethamine + sulfadiazine versus spiramycin for prevention of congenital toxoplasmosis transmission
2010-019972-65Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in toxoplasmosis and congenital toxoplasmosis comparing Pyrimethamine + sulfadiazine with Spiramycin (2 arms). Primary endpoint: Maternal-fetal transmission rate of Toxoplasma gondii. Started Jun 2010; status: active.
02
Drugs
pyrimethamineSulfadiazinespiramycin
03
Conditions
toxoplasmosiscongenital toxoplasmosis
Beyond the preview
Go deeper on 2010-019972-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019972-65.